From: Genetic profiling of patients with adenoid cystic carcinoma of the Bartholin’s glands reveals potential new routes for targeted therapies: a case report
Case
Gene alteration
VAF (%)
CN
Pathogenicity
1
KRAS G12D
12.4
2.20
Pathogenic
2
KDM6A c.2832 + 1G > C
41.9
2.06